Introduction
Prostate cancer is one of the most prevalent malignancies and the second leading cause of cancer deaths in men in the United States. Clinically, it is usually diagnosed in patients over 50 years old. Thus, there is a promising opportunity for intervention using cancer chemopreventive compounds that prevent or slow the progression of this disease. Recent studies have suggested that using dietary chemopreventive compounds is a very promising strategy to decrease the incidence of prostate cancer (Chiao et al., 2002; Willis and Wians, 2003) . Many epidemiological studies have shown that consumption of vegetables such as cruciferous vegetables can reduce the risk of different kinds of cancer in humans (Steinmetz and Potter, 1996; Hecht, 2000; Talalay and Fahey, 2001) . Some isothiocyanates (ITCs), including sulforaphane (SFN) derived from cruciferous vegetables, are highly effective in preventing or reducing the risk of cancer induced by carcinogens in animal models (Hecht, 2000; Kong et al., 2001; Talalay and Fahey, 2001; Singh et al., 2004) . Studies have indicated that SFN and phenethyl isothiocyanate (PEITC) could reduce the risk of prostate cancer in animal models, inhibit prostate cancer cell growth, induce apoptosis, and retard growth of prostate cancer cell xenografts in vivo (Brooks et al., 2001; Chen et al., 2002; Chiao et al., 2002; Xiao and Singh, 2002; Singh et al., 2004) . Among the mechanisms observed in these studies, ITCs were involved in caspase-mediated apoptosis , MAPK cascade regulation (Chen et al., 2002; Xiao and Singh, 2002) , phase II gene induction (Brooks et al., 2001) , and cell cycle regulation (Chiao et al., 2002) .
Consisting of homo-and heterodimeric complexes formed from the Rel family of proteins, Rel/NF-kB nuclear transcription factors have been found to play an important role in cell proliferation, apoptosis, and cancer development (Amit and Ben-Neriah, 2003; Aggarwal et al., 2004) . The Rel protein family consists of five proteins, named c-Rel, Rel A (p65), Rel B, NFkB1 (p50/p105), and NF-kB2 (p52/p100). The most common nuclear factor kappa B (NF-kB) is a heterodimer composed of p65 and p50 (Greten and Karin, 2004; Suh and Rabson, 2004) . NF-kB is activated by a wide variety of stimuli such as tumor necrosis factor (TNF)-alpha, interleukin-1 (IL-1), LPS, UV light, and oxidative stress (Jeong et al., 2004; Takada et al., 2004b) . In most cell types, NF-kB is present in the cytosol in an inactive form and is associated with its inhibitor proteins, called inhibitor of NF-kB (IkBs). IkBs family members include IkBa, IkBb, IkBe, and Bcl-3, with IkBa being the prototypical member of this family (Suh and Rabson, 2004) . Of the many functional domains in NF-kB proteins, -the Rel homology domain (RHD), DNA-binding domains, the dimerization domain, and the nuclear localization signal (NLS), IkBs bind to the RHD. Activation of NF-kB by extracellular stimuli leads to rapid phosphorylation, ubiquitination, and proteolytic degradation of IkBa, thereby exposing the nuclear localization signals on NFkB and resulting in the nuclear translocation of NF-kB complex and phosphorylation of p65. The binding of NF-kB to a specific sequence in the promoter region of a gene triggers the transcriptional activation of NF-kBregulated genes including cyclin D1, vascular endothelial growth factor (VEGF), Bcl-X L , COX-2, and MMP-9, which are involved in a variety of cellular events, including tumor cell proliferation, cell death, angiogenesis, and metastasis (Amit and Ben-Neriah, 2003; Takada et al., 2003) .
The phosphorylation of IkBa (Ser32 and Ser36) is believed to be catalysed by IkB kinases (IKKs). The IKK complex is a 700-900 kDa protein kinase complex composed of catalytic (IKKa and IKKb) and regulatory (IKKg) subunits. While the catalytic activity of IKKa and IKKb on IkBa phosphorylation is different and depends on the cell type, IKKb is the main component involved (Senftleben et al., 2001; Gasparian et al., 2002a; Suh and Rabson, 2004) . Recent studies revealed that the protein-tyrosine kinase Syk could phosphorylate IkBa through tyrosine and activate NF-kB (Fan et al., 2003; Takada et al., 2003) . It is still controversial which kinase is responsible for the phosphorylation of p65, but the phosphorylation of p65 at serine 529 is known to be required for NF-kB transcriptional activation (Takada et al., 2004b) . NF-kB has been reported to play an important role in several signal transduction pathways involved in various cancers as well as in chronic inflammatory diseases (Rayet and Gelinas, 1999; Bremner and Heinrich, 2002; Aggarwal et al., 2004) . SFN was reported to selectively reduce DNA binding of NF-kB without interfering with LPSinduced degradation of the inhibitor of NF-kB nor with nuclear translocation of NF-kB, and NF-kB was identified as the key mediator for sulforaphanemediated anti-inflammatory mechanisms (Heiss et al., 2001) . SFN was found to interact with the thiol groups by dithiocarbamate formation, and believed to impair the redox-sensitive DNA binding and transactivation of NF-kB. SFN could either directly inactivate NF-kB subunits by binding to essential Cys residues or interact with glutathione or other redox regulators such as thioredoxin and Ref-1 proteins relevant for NF-kB function (Heiss et al., 2001) . Human prostate cancer PC-3 cell is an androgen-independent cell line lacking androgen receptor. In this cell line, aberrant IKKs activation is believed to lead to heavy phosphorylation of IkBa and constitutive activation of NF-kB. It is believed that inhibition of IKKs, IkBa, and NF-kB activation in prostate cancer may prove useful both in prevention and adjuvant therapy (Gasparian et al., 2002a) . Based on those mechanisms or hypotheses, compounds that can inhibit NF-kB have been shown to be effective against carcinogenesis and cancer promotion (Manna et al., 1999; Holmes-McNary and Baldwin, 2000; Nomura et al., 2000; Huang et al., 2001; Mathas et al., 2003) . For example, apigenin and selenium compounds were recently reported to suppress NF-kB activation, to induce apoptosis, and to exert their chemoprevention or sensitization effects in prostate cancer cell lines (Gasparian et al., 2002b; Shukla and Gupta, 2004 ). SFN and PEITC were able to induce apoptosis in human prostate androgen-insensitive PC-3 cells through mechanisms involving MAPK signaling pathways and caspase-mediated apoptosis (Xiao and Singh, 2002; Singh et al., 2004) . Benzyl isothiocyanate (BITC), a close structural analogue of PEITC derived from cruciferous vegetables was reported to decrease nuclear translocation and DNA-binding capacity of NF-kB as well as cyclin D1 expression in human pancreatic cancer BxPC-3 cell line (Srivastava and Singh, 2004) . Given the important roles of NF-kB in carcinogenesis, transformation, apoptosis, and chemoprevention, we first examined the effects of SFN and PEITC on NF-kB transcriptional activation and NFkB-regulated gene expression in human prostate cancer PC-3 cells. We then investigated the possible mechanisms involved in the modulations of IKKs and IkBa in ITC-mediated changes of NF-kB-regulated gene expression.
Results

SFN and PEITC decrease the cell viability of PC-3 C4 cells
The effects of SFN and PEITC on the viability in PC-3 C4 cells were determined by a colorimetric MTS assay after 24 h treatment. Both SFN and PEITC exhibited growth inhibitory effects on PC-3 C4 cells. The cell viability by SFN at 20, 30, and 40 mM was 85, 73, and 44%, respectively, and the cell viability by PEITC at 5, 7.5, and 10 mM was 87, 76, and 35%, respectively. PEITC was more potent inhibitor of cell viability than SFN. After PC-3 C4 cells were exposed to UVC 50 J/m 2 , the cell viability at 24 h was 91%. Pretreatment with PC-3 C4 cells with 20 and 30 mM of SFN for 2 h, then exposed to UVC 50 J/m 2 , the cell viability at 24 h was 83 and 76%, respectively. Similarly, pretreatment with 5 or 7.5 mM of PEITC in PC-3 C4 cells, following exposure to UVC irradiation, the cell viability was 88 and 74%, respectively.
SFN and PEITC inhibit NF-kB transcriptional activity
To investigate and compare the effects of SFN and PEITC on NF-kB transcriptional activity, we performed dose-response and time-dependent experiments of these two ITCs in the PC-3 C4 cells as described above. Since TPA, LPS, TNF-a, and epidermal growth factor (EGF) have no significant inducible effect on NF-kB transcriptional activity in PC-3 C4 cells (data not shown), we utilized UVC exposure as the positive activator for NFkB transcriptional activation.
After treatments with SFN and PEITC for 6 h, compared with control, 30 and 40 mM SFN significantly inhibited NF-kB transcriptional activity by 30 and 55% (Po0.05). In all, 20 mM SFN inhibited NF-kB transcriptional activity by 12% without any statistical significance (P>0.05). Similar to SFN, 7.5 and 10 mM PEITC significantly inhibited NF-kB transcriptional activity by 35 and 53% (Po0.05). In all, 5 mM PEITC did not show any significant inhibition (P>0.05). However, 20 mM SFN and 5 mM PEITC could significantly inhibit NF-kB transcriptional activity by 23 and 22% (Po0.05), respectively, if the treatment time was extended to 12 h instead of 6 h.
As shown in Figure 1a and b, after treatment for 24 h, both SFN and PEITC at lower concentrations slightly induce NF-kB transcriptional activity, but not significantly. SFN starting from 20 mM and PEITC starting from 5 mM potently inhibited NF-kB transcriptional activity. Compared with control, 20 and 30 mM SFN inhibited NF-kB transcriptional activity by 29 and 48%, respectively. Similar to SFN, 5 and 7.5 mM PEITC inhibited NF-kB transcriptional activity by 30 and 50%, respectively, compared with control.
After PC-3 C4 cells were exposed to UVC 50 J/m 2 , and cultured for 6, 12, or 24 h, the NF-kB transcriptional activity was increased by 35, 87, and 280%. Therefore, we have selected the incubation time of 24 h after UVC exposure to investigate the following inhibitory interaction between SFN, PEITC, and UVC. The basal luciferase activity of the control cells was 44 00073400 RLU/s, and following UVC irradiation at 24 h, the luciferase activity was elevated to 168 00079800 RLU/s, with an increase of 2.8-fold.
To further elucidate the effects of SFN and PEITC on NF-kB transcriptional regulation, PC-3 C4 cells were pretreated with 20 and 30 mM SFN or 5 and 7.5 mM PEITC for 2 h and then exposed to 50 J/m 2 UVC, and then cultured for additional 24 h. The result indicated that pretreatment with both SFN and PEITC substantially inhibited UVC-induced NF-kB transcriptional activation ( Figure 1c ) and that the inhibitory effect of SFN was stronger than that of PEITC. Similarly, when SFN and PEITC were added immediately or 2 h after the cells were first exposed to UVC, UVC-induced NFkB transcriptional activation was also potently inhibited (data not shown).
dnIKKb and SR-IkBa inhibit NF-kB transcriptional activity
To investigate the possible role of IKKb and IkBa in the regulation of NF-kB transcriptional activity in PC-3 C4 Suh et al., 2002) . Briefly, PC-3 C4 cells were transfected with SR-IkBa or dnIKKb using 1 to 2 mg as described in the Materials and methods. At 5 h after transfection, the media were changed to normal MEM containing 10% FBS, and the luciferase activity was measured at 24 h. The controls were transfected with pcDNA3.1 plasmid vector. As expected, dnIKKb and SR-IkBa potently inhibited the basal NF-kB transcriptional activity compared with control and also blocked the UVC-induced NF-kB transcriptional activation. The blocking capacity of dnIKKb on NF-kB transcriptional activation was slightly stronger than that of SR-IkBa. We also transfected a constitutively active form of IKKb into PC-3 C4 cells but only observed a slight induction of NF-kB transcriptional activation. As it has been shown, PC-3 cells are IKKs aberrant and NF-kB is constitutively activated, the basal activities of IKKs and NF-kB are very high (Gasparian et al., 2002b; Suh and Rabson, 2004) . Possibly because of this reason that dnIKKb could significantly inhibit NF-kB transcriptional activation, while constitutively active form of IKKb only had a marginal effect on NF-kB transcriptional activation.
SFN, PEITC, dnIKKb, and SR-IkBa inhibit VEGF, cyclin D1, and Bcl-X L expression
Recent studies showed that regulation of VEGF, cyclin D1, and Bcl-X L is associated with NF-kB (Huang et al., 2001) . To further understand the effects of SFN and PEITC on NF-kB and NF-kB-regulated gene expression, we treated PC-3 C4 cells with SFN and PEITC for 7 and 24 h, as well as transfected cells with dnIKKb and SR-IkBa for 7 h. The results indicated that both SFN and PEITC significantly inhibited NF-kB-regulated VEGF, cyclin D1, and Bcl-X L expression (Figure 2a and b). In particular, 7.5 mM PEITC inhibited most of the expression of Bcl-X L at 7 and 24 h. The inhibition by SFN and PEITC at 24 h was stronger than that after 7 h (Figure 2a and b) . Similarly, the inhibition of VEGF, cyclin D1, and Bcl-X L expression was also observed when PC-3 C4 cells were transfected with dnIKKb and SR-IkBa (Figure 2c ). Consistent with the results obtained above showing that the NF-kB transcriptional activities were inhibited by SFN and PEITC after 6 h, and that the inhibition after 24 h was greater than that after 6 h. This result was corroborative with the inhibition of NF-kB-responsive VEGF, clyclin D1, and Bcl-X L expression.
SFN, PEITC, and dnIKKb inhibit phosphorylation and degradation of IkBa
Since SFN and PEITC inhibited transcriptional activity as well as NF-kB-regulated VEGF, cyclin D1, and Bcl-X L expression in PC-3 cells, we next investigated the regulation of upstream members of NF-kB signaling pathway. We specifically assessed IkBa, which retains NF-kB in the cytosol and prevents NF-kB translocation into the nucleus because our previous results showed that dominant-negative mutant IkBa (SR-IkBa) inhibited NF-kB transcriptional activity and VEGF, cyclin D1, and Bcl-X L expression (Figure 2c) . Thus, the effects of SFN and PEITC observed in PC-3 C4 cells might act through the regulation of IkBa phosphorylation and degradation. Our results indicated that treatment with SFN and PEITC for 2 h significantly inhibited phosphorylation of IkBa ( Figure 3a ) and that pretreatment with SFN and PEITC for 2 h also potently blocked UVC-induced phosphorylation of IkBa ( Figure 3b ). As a positive control, the dominant-negative IKKb also potently inhibited IkBa phosphorylation (Figure 3c ). The IkBa degradation occurred very soon after PC-3 C4 cells were exposed to UVC, after 15 min, with obvious degradation. While the degradation peaked at 30 min later, IkBa reformed at 60 min after UVC exposure. Pretreatment with 30 mM SFN and 7.5 mM PEITC for 2 h blocked the obvious degradation of IkBa after UVC exposure compared with no pretreatment (Figure 4 ).
As it is generally known, the phosphorylation of IkBa is quite a rapid process, and our results showed that IkBa was resynthesized in 1 h following PC-3 C4 cells exposure to UVC. The levels of IkBa after PC-3 C4 cells exposed to UVC was significantly decreased within 1 h, Figure 2 Effects of SFN, PEITC, dnIKKb, and SR-IkBa on VEGF, cyclin D1, and Bcl-X L expression in PC-3 C4 cells. Briefly, PC-3 C4 cells were treated with SFN and PEITC for 7 h (a); 24 h (b); or (c) cells were transfected with dnIKKb and SR-IkBa for 5 h followed by replacement of media with normal MEM for an additional 2 h. The whole-cell lysis extracts were collected to run the Western blot against VEGF, cyclin D1, and Bcl-X L according to that described in the Materials and methods. b-Actin is included as a loading control Suppression of NF-jB by isothiocyanates C Xu et al and therefore, to have a more reasonable comparison to UVC-induced phosphorylation of IkBa in the absence or presence of SFN and PEITC, we have selected the 2 h treatment time in these phosphorylation experiments.
SFN and PEITC inhibit IKKa and IKKb phosphorylation
From the above results, we found that SFN and PEITC inhibited phosphorylation of IkBa (Figure 3a and b) . Recent studies showed that IKKs are the upstream kinases of IkBa, so we expected SFN and PEITC to also inhibit IKKa and IKKb phosphorylation in PC-3 C4 cells. The results showed that treatment with SFN and PEITC potently inhibited phosphorylation of IKKa and IKKb (Figure 5a ), and pretreatment with SFN and PEITC also strongly blocked UVC-induced phosphorylation of IKKa and IKKb (Figure 5b ). The total protein levels of IKKa and IKKb after short time treatment with SFN and PEITC or UVC irradiation did not change substantially.
SFN and PEITC inhibit IKKa and IKKb activity
Since SFN and PEITC inhibited phosphorylation of IKKa and IKKb as well as phosphorylation of their putative downstream substrate IkBa, we assessed the downstream effects of such treatment on IKKa and IKKb activity. Using the full length IkBa (1-317) as the substrate, whole-cell lysis extracts were immunoprecipitated (IP) with antibodies against IKKa or IKKb. Following in vitro kinase assay, we found that after treatment with SFN and PEITC for 2 h in PC-3 C4 cells inhibited phosphorylation of IkBa mediated by the IKKb IP extract (Figure 6a ). The basal phosphorylation of IkBa mediated by the IKKb IP extract was much stronger than that mediated by the IKKa IP extract (Figure 6b) , and the inhibition of IkBa phosphorylation mediated by the IKKa IP extract after treatment with SFN and PEITC for 2 h in PC-3 C4 cells was much weaker than that mediated by the IKKb IP extract (Figure 6b ). Interestingly, both IKKa and IKKb IP extracts contained the other isoform, although at lesser quantities as indicated by the Western blot ( Figure 6 ). Since IKK complexes are composed of IKKa and IKKb, it is reasonable for IKKa and IKKb to exist in IKKb and IKKa IP extracts, respectively. Thus, we concluded that phosphorylation of IkBa is mainly mediated by IKKb compared with IKKa in PC-3 C4 cells. There were no obvious changes in total IKKa and IKKb expression after treatment with SFN and PEITC (Figure 6a and b) , although the phosphorylation of IKKa and IKKb was significantly inhibited by SFN and PEITC (Figure 5a ). , and then cultured for an additional 2 h; (c) cells were transfected with dnIKKb for 5 h followed by replacement of media with normal MEM for an additional 2 h. All samples were then analysed by Western blot against phosphorylated IkBa and total IkBa protein according to that described in the Methods. b-actin is included as a loading control Figure 4 Effects of SFN and PEITC on IkBa degradation induced by UVC in PC-3 C4 cells. Briefly, PC-3 C4 cells were pretreated with 30 mM SFN or 7.5 mM PEITC. After 2 h cells were exposed to UVC 50 J/m 2 , and whole-cell lysis extracts were prepared after 15, 30, 60, or 120 min. Western blot against IkBa was run according to the Materials and methods. b-Actin is included as a loading control Suppression of NF-jB by isothiocyanates C Xu et al
SFN and PEITC inhibit the level of p65 in the nucleus
After phosphorylation and degradation of IkBa, the p65/p50 NF-kB complex is released from IkBa and translocated into nucleus. Recent studies have shown that the p65 subunit is directly phosphorylated by an upstream kinase before activating downstream genes (Catley et al., 2004; Takada et al., 2004b) . Based on those results, we tested whether SFN and PEITC could also inhibit the nuclear translocation and phosphorylation , and cultured for an additional 2 h. The wholecell lysis extracts were prepared, and Western blots against phosphorylated IKKs as well as the total IKKs protein were run according to the Materials and methods. b-Actin is included as a loading control Figure 6 Effects of SFN and PEITC on IKKa and IKKb activity. Briefly, PC-3 C4 cells were treated with SFN or PEITC for 2 h, the whole-cell lysis extracts were prepared, and 500 mg of protein extract was immunoprecipitated with antibodies against (a) IKKa and (b) IKKb, respectively. In vitro kinase assays were performed according to the Materials and methods. Protein extract (30 mg) was immunoprecipitated with antibodies against IKKa or IKKb followed by Western blot to examine the effect of SFN and PEITC on IKKa and IKKb activity Suppression of NF-jB by isothiocyanates C Xu et al of p65. As expected, treatment with SFN and PEITC for 2 h significantly inhibited the phosphorylation of p65 in the nucleus (Figure 7a ), but the protein levels of p65 in the nucleus were also significantly reduced (Figure 7a) . Thus, the decreased phosphorylation of p65 in the nucleus was mainly due to the decreased nuclear translocation of p65 by treatment with SFN and PEITC in PC-3 C4 cells. Pretreatment with SFN and PEITC blocked the elevated nuclear translocation of p65 induced by UVC irradiation to the control level in PC-3 C4 cells, as well as the total phosphorylation of p65 induced by UVC exposure (Figure 7b ).
Discussion
Prostate cancer is the second leading cause of cancer death in men in the United States. While the incidence of prostate cancer has increased steadily over the years, the etiology is still not exactly clear but may involve genetic changes, activated oncogenes, growth factors, androgen hormones, and/or dietary factors (Cohen et al., 2000; Willis and Wians, 2003) . Recent studies suggest that high consumption of vegetables, particularly cruciferous vegetables, is associated with a reduced risk of prostate cancer (Cohen et al., 2000; Kolonel et al., 2000; Willis and Wians, 2003) . Many isothiocyanates, found abundantly in cruciferous vegetables, have been found to effectively block chemically induced carcinogenesis in various animal models (Brooks and Paton, 1999; Hecht, 2000; Talalay and Fahey, 2001) . SFN was observed to be a potent inducer of phase II detoxifying enzymes in human prostate cells, the induction of which could explain the association between high consumption of cruciferae and decreased prostate cancer risk (Brooks et al., 2001) . PEITC was also recently reported to potently inhibit cell growth and induce apoptosis in human PC-3 prostate cancer cells (Xiao and Singh, 2002) .
Human prostate cancer PC-3 cells are a p53-mutant and PKC-deficient cell line (Henttu and Vihko, 1998; Xiao and Singh, 2002) . TPA, LPS, TNF-a, and EGF have no significantly inducible effect on NF-kB transcriptional activity (measured by luciferase reporter gene activity) in PC-3 C4 cells (data not shown). In this study, we utilized UVC exposure as a positive control to study the mechanism of NF-kB regulation initiated by SFN and PEITC in PC-3 C4 cells.
Activation of NF-kB signaling pathways by extracellular stimuli leads to rapid phosphorylation, ubiquitination, and proteolytic degradation of IkBa, resulting translocation of NF-kB to the nucleus where it regulates gene transcription (Amit and Ben-Neriah, 2003; Takada et al., 2003) . Previous study from our laboratory indicated that the peak plasma concentration of SFN of 20 mM was obtained at 4 h after an oral dose of 50 mmol of SFN in the rat , a dose which had been shown to be effective in the prevention of AOM-induced colon cancer model (Chung et al., 2000) . Since SFN at concentrations of 20 and 30 mM and PEITC at concentrations of 5 and 7.5 mM could significantly inhibit basal NF-kB transcriptional activity (Figure 1 ) with cell viability greater than 70% , we chose these concentrations for our study. We found that both SFN and PEITC could potently inhibit basal and UVCinduced IkBa phosphorylation (Figure 3) , consistent with the inhibition of NF-kB transcriptional activity in the luciferase reporter assay elicited by SFN and PEITC (Figure 1) . SFN was also reported to inhibit , and cultured for an additional 2 h. The nuclear extracts were prepared, and Western blots against phosphorylated p65 and total p65 protein were run according to the Materials and methods. bActin is included as a loading control Suppression of NF-jB by isothiocyanates C Xu et al LPS-induced NF-kB DNA-binding capacity in macrophages (Heiss et al., 2001 ). We did not test the DNAbinding capacity in our study; however, it is highly possible that this might have also occurred in the treatment with SFN and PEITC in PC-3 C4 cells, as indicated by the decrease in the translocation of p65 into the nucleus and the decrease in the transcriptional activation of NF-kB luciferase activity and NF-kBregulated genes. Transient transfection of dominantnegative IkBa resulted in a very similar inhibitory effect on NF-kB transcriptional activity compared with SFN and PEITC. After UVC exposure, the degradation of IkBa appeared at 15 min and peaked 30 min later. Pretreatment with SFN and PEITC significantly blocked the degradation of IkBa (Figure 4 ). Taken together, these results indicate that SFN and PEITC treatment inhibits IkBa phosphorylation and its rapid degradation and therefore suppresses NF-kB transcriptional activity in PC-3 C4 cells.
The phosphorylation of IkBa (Ser32 and Ser36) is mediated by upstream IKKs, including IKKa and IKKb (Greten and Karin, 2004) . Flavopiridol and protein farnesyltransferase inhibitor SCH 66336 have been reported to inhibit TNF-induced IKK activity in Jurkat and A293 cell lines, exerting their inhibitory effects on NF-kB and NF-kB-regulated gene expression Takada et al., 2004a) . In our study treatment with SFN and PEITC also significantly inhibited the basal as well as UVC-induced IKKb and IKKa phosphorylation ( Figure 5 ). Since transfection of PC-3 C4 cells with dominant negative IKKb could potently inhibit both basal and UVC-induced NF-kB transcriptional activity, IKKb is directly involved in the regulation of NF-kB transcriptional expression in PC-3 C4 cells. Since IkBa is the downstream kinase of IKKb and IkBa is the upstream kinase of NF-kB regulation, it is not surprising that transfection of dnIKKb into PC-3 C4 cells could block the phosphorylation of IkBa (Figure 3c ). Thus, we hypothesized that suppression of NF-kB transcriptional activity by SFN and PEITC might be mediated by the inhibition of IKKs. In this current study, treatment with SFN and PEITC significantly decreased the phosphorylation of IKKb (Figure 5 ), although the total expression of IKKb did not obviously change. In the in vitro kinase assay using IkBa as the substrate, treatment with SFN and PEITC strongly inhibited the IKKb activity (Figure 6a ). Interestingly, the basal activity of IKKa was much weaker than that of IKKb in PC-3 C4 cells (Figure 6b ). These results indicate that SFN and PEITC could inhibit IKKs, especially IKKb phosphorylation activity in PC-3 C4 cells, and that IKKb, not IKKa, is probably the main regulator of IkBa phosphorylation in PC-3 C4 cells.
Previous studies have shown that flavopiridol and protein farnesyltransferase inhibitor SCH 66336 could inhibit TNF-induced p65 phosphorylation Takada et al., 2004a) and this inhibition is thought to be one mechanism of NF-kB blockage elicited by those compounds. Our results indicated that the basal and UVC-induced phosphorylation of p65 at serine 529 was significantly decreased by SFN and PEITC, but the protein levels of p65 in the nucleus were also decreased substantially (Figure 7) . Thus, the inhibition of phosphorylated p65 in the nucleus was mainly due to the decrease of nuclear translocation of p65 by treatment with SFN and PEITC in PC-3 C4 cells, and not by the direct inhibition of phosphorylation elicited by SFN and PEITC. Phosphorylation of p65 at serine 529 is known to be required for NF-kB transcriptional activation (Takada et al., 2004b) . Since SFN and PEITC could inhibit the basal and UVCinduced NF-kB transcriptional activity, our results suggest that inhibition on NF-kB transcriptional activation by SFN and PEITC is possibly due to the inhibition of nuclear translocation of p65 and consequently phosphorylation of p65 in PC-3 C4 cells.
Recent studies show that blockage of NF-kB transcriptional activity is associated with suppression of angiogenesis, invasion, and metastasis (Huang et al., 2001; Suh and Rabson, 2004; Takada et al., 2004a) . NFkB-regulated target genes involved in those cellular events in PC-3 C4 cells include VEGF, cyclin D1, and Bcl-X L (Suh and Rabson, 2004) . In our study, VEGF, cyclin D1, and Bcl-X L expression levels were analysed after treatment with SFN and PEITC for 7 and 24 h in PC-3 C4 cells, and as expected, SFN and PEITC could significantly inhibit expression of these NF-kB-regulated genes (Figure 2a and b) . Similar inhibitory effects on VEGF, cylcin D1, and Bcl-X L expression were found after transfection of PC-3 C4 cells with dnIKKb and SR-IkBa (Figure 2c ), suggesting a specific role for NFkB signaling pathways in the regulation of VEGF, cyclin D1, and Bcl-X L gene expression in response to SFN and PEITC. Huang et al. (2001) found that blockade of NFkB signaling significantly inhibited VEGF, IL-8, and MMP-9 expression in PC-3 cells, and hence decreased neoplastic angiogenesis. PC-3 cell line is androgenindependent, it can produce growth factors and cytokines, for example, VEGF, TNF-a, IL-6, and IL-8. These growth factor and cytokines are activators of IKKs and consequently NF-kB. Thus, there is an assumption that activation of IKKs and NF-kB in PC-3 cells involves an established positive autocrine/ paracrine loop (Gasparian et al., 2002a) . From our results, we found that the inhibition of phosphorylation of IKKs and IkBa by SFN and PEITC preceded the effects on NF-kB-regulated gene expression. However, it is also possible that the decreased expression of growth factors and cytokines can contribute to more inhibition of phosphorylation of IKKs and IkBa elicited by SFN and PEITC due to the autocrine/paracrine loop.
NF-kB-regulated genes such as VEGF, cyclin D1, Bcl-X L , COX-2, and MMP-9 are tightly involved with tumorigenesis, cell proliferation, cell death, tumor angiogenesis, invasion, and metastasis. Thus, the potent inhibition of NF-kB transcriptional activation and NF-kB-regulated gene expression elicited by SFN and PEITC indicates a potential and promising pathway for the chemoprevention and chemotherapy of cancer by natural compounds. It also suggests the potential importance and role of SFN and PEITC on the Suppression of NF-jB by isothiocyanates C Xu et al chemoprevention and chemotherapy of tumors including prostate cancer.
Taken together, these two isothiocyanates, SFN and PEITC, inhibited IKKs phosphorylation, particularly the inhibition of IKKb, leading to the inhibition of phosphorylation of IkBa mediated by IKKb. This would in turn lead to a decrease in the ubiquitination and proteolytic degradation of IkBa, and subsequently NF-kB was retained in the cytosol and decreased the nuclear translocation of p65. As a result, the NF-kBregulated VEGF, cyclin D1, and Bcl-X L gene expression was attenuated.
Materials and methods
Materials
SFN was obtained from LKT laboratories, and PEITC was purchased from Sigma. Luciferase assay reagent was bought from Promega. Antibodies against phospho-IKKa (Ser180)/ IKKb(Ser181), phospho-IkBa(Ser32), IKKa, and IKKb were purchased from Cell Signaling Technology. The full-length IkBa(1-317) protein and antibodies against VEGF, cyclin D1, Bcl-X L , and IkBa were bought from Santa Cruz Biotechnology. Antibody recognizing p65 phosphorylated at serine 529 was bought from Rockland Laboratories. The NF-kBluciferase reporter plasmid constructs containing NF-kB consensus binding sites were kindly provided by Dr Anning Lin (University of Chicago, IL, USA). SR-IkBa was generated as previously described (Suh et al., 2002) , and dnIKKb was generated as previously described by O'Mahony et al. (2000) .
Cell culture
Human prostate cancer PC-3 cells were obtained from American Type Culture Collection (Rockville, MD, USA). The cells were maintained in minimum essential medium (MEM) supplemented with 10% fetal bovine serum (FBS), 2.2 g/l sodium bicarbonate, and 10 ml/l PSN Antibiotic Mixture (GibcoBRL, Grand Island, NY, USA) in a humidified atmosphere of 5% CO 2 and 95% air at 371C. Prior to treatment, the medium was removed when cells were about 80% confluent, and cells were maintained overnight in low serum MEM containing 0.5% FBS. During the treatment with compounds, the FBS concentration was also 0.5%.
Stable transfection and transient transfection
NF-kB luciferase construct was stably transfected into PC-3 cells by Lipofectaminet 2000 (LF2000, Invitrogen Life Technology) following the manufacturer's instructions. AT 5 h after transfection, the media were replaced with MEM containing 10% FBS, and the cells were selected with G418 to obtain single stable cell clones. PC-3 C4 cell line was a single stable clone transfected with an NF-kB-luciferase reporter construct and was used for the following experiment. The transient transfection was performed using the same procedure as stable transfection without G418 selection.
MTS assay
The MTS [3-(4,5-dimethyltiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H-tetrazolium, inner salt] assay was performed with CellTiter 96 Aqueous Non-Radioactive Cell Proliferation Assay Kit (Promega Corp. Madison, WI, USA) according to the manufacturer's instructions. Briefly, PC-3 C4 cells were plated onto 24-well plates, the density was 1 Â 10 5 /well, after 24 h growth media were replaced with media containing 0.5% serum overnight. Cells were then treated with different concentrations of SFN or PEITC for 24 h. The media were removed, and culture media containing MTS and phenazine methosulfate solution were added. About 30 min later, the absorbance was measured at 490 nm with a mQuant ELISA reader (BIO-TEK Instruments, Inc., Madison, WI, USA). The data were expressed as percent cell viability compared to that of the control, which was treated with 0.1% DMSO or ethanol; SFN dissolved in DMSO and PEITC dissolved in ethanol, respectively. The data were expressed as mean (n ¼ 4)7SD. Every MTS assay experiment was repeated twice for reproducibility.
NF-kB-dependent reporter gene expression assay NF-kB transcriptional activity was measured by NF-kBluciferase reporter gene expression. PC-3 C4 cells were treated with different concentrations of SFN or PEITC for 24 h, and the NF-kB-luciferase activities were measured according to the manufacturer's instructions (Promega). Briefly, after treatments the cells were washed with ice-cold phosphate bufferedsaline (PBS) and harvested in 1 Â reporter lysis buffer. After centrifugation, 10-ml aliquots of the supernatants were measured for luciferase activity by using a Sirus Luminometer (Berthold Detection Systems GmbH D-75173 Pforzheim, Germany). The luciferase activity was normalized against known protein concentrations and expressed as fold induction of luciferase activity over the control cells, which were treated with 0.1% DMSO or ethanol. The protein level was determined by Bio-Rad protein assay according to the manufacturer's instructions. When applicable, statistical Student's t-tests were performed, and Po0.05 was considered significant.
Western blot analysis
PC-3 C4 cells were plated onto six-well plates with a density of 4 Â 10 5 /well. After 24 h, the growth media were replaced with media containing 0.5% serum and grown overnight. Cells were then treated with SFN and PEITC for different times, exposure to UVC, or transiently transfected with upstream kinase cDNA plasmids. Whole-cell lysis extracts or nuclear extracts were prepared as described previously (Gasparian et al., 2002a; Takada et al., 2003) . As determined by Bio-Rad protein assay, 20 mg of total protein from each sample was mixed with 4 Â loading buffer and heated at 901C for 4 min. Proteins were then separated by 10% mini-SDS-polyacrylamide gel electrophoresis (PAGE) and transferred onto polyvinylidene fluoride (PVDF) membrane using a semi-dry transfer system (Fisher). The membrane was then blocked with 5% bovine serum albumin (BSA) or 5% nonfat milk in TBST buffer (2.42 g/l Tris-HCl, 8 g/l NaCl, 1 ml/l Tween-20, pH 7.6), washed with TBST buffer, and incubated overnight at 41C with primary antibodies prepared in TBST buffer. The membrane was then washed with TBST and incubated with secondary antibody conjugated with horseradish peroxidase (Santa Cruz Biotechnology Inc.). After washing with TBST, the detection was performed with enhanced chemiluminescence (ECLt) Western blotting reagents (Amersham Pharmacia Biotech, Piscataway, NJ, USA).
In vitro IkB kinase assay
In vitro IkB kinase assay was performed by a method described previously (Gasparian et al., 2002a; Takada et al., 2004a) .
Briefly, PC-3 C4 cells were plated onto 10-cm petridishes with a density of 5 Â 10 6 /well. After 24 h, the growth media were replaced with media containing 0.5% serum overnight. Cells were then treated with SFN or PEITC for 2 h, and whole-cell lysis extracts were prepared as described previously (Gasparian et al., 2002a) . IKKa and IKKb from whole cell lysis extracts was immunoprecipitated with antibody against IKKa and IKKb, respectively, followed by treatment with protein ASepharose beads (Zymed Laboratories Inc.). After incubation overnight at 41C, the beads were washed with lysis buffer and kinase assay buffer (20 mM HEPES, pH 7.4, 10 mM MgCl 2 , 2 mM MnCl 2 , 2 mM dithiothreitol, 50 mM b-glycerophosphate, 10 mM p-nitrophenyl phosphate, and 0.1 mM sodium orthovandate). Kinase reactions were initiated by the addition of 30 ml of kinase assay buffer containing 2 mCi of [g-32 P]ATP, 10 mM unlabeled ATP, and 10 mg of substrate full-length IkBa (amino acids 1-317). After incubation at 301C for 30 min, the reaction was terminated by boiling with SDS-PAGE loading buffer for 5 min. Finally, the protein was resolved on 10% SDS-PAGE, the gel was stained and dried, and the phosphorylation of IkBa was visualized by autoradiography and quantitated with by phosphorimager. Abbreviations ITC, isothiocyanate; SFN, sulforaphane; PEITC, phenethyl isothiocyanate; NF-kB, nuclear factor kappa B; IkBa, inhibitor of NF-kB alpha; IKK, IkB kinase; VEGF, vascular endothelial growth factor.
